MOTS-c: An Overview of Current Research Literature

Quick answer: MOTS-c is a peptide encoded within mitochondrial DNA, in a small open reading frame of the 12S rRNA region, and belongs to the mitochondrial-derived peptide class. Researchers study it in cell and animal models for metabolic regulation, including glucose metabolism and insulin sensitivity, mitochondrial-nuclear communication and metabolic stress responses. It is sold for laboratory research use only.

What Is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded within mitochondrial DNA rather than nuclear DNA — a relatively recent discovery in the broader field of mitochondrial-derived peptides (MDPs). This origin makes it a distinct subject of interest in metabolic and cellular research, separate from more commonly studied synthetic analogs.

This overview is intended for laboratory and research audiences. MOTS-c, as sold by research suppliers, is not approved for human or animal use and is not a drug or supplement.

Discovery and Background

MOTS-c was identified as part of research into the mitochondrial genome’s coding capacity beyond its traditionally recognized genes. Researchers found that this small open reading frame produced a functional peptide capable of exerting effects observed in cell and animal models, prompting further investigation into its role in cellular metabolism.

Areas of Scientific Interest

Within the published literature, MOTS-c research has largely concentrated on:

  • Metabolic regulation — studies have examined MOTS-c’s relationship to glucose metabolism and insulin sensitivity in animal models
  • Mitochondrial-nuclear communication — as a mitochondrial-derived peptide, MOTS-c is studied as part of a signaling pathway between mitochondria and the nucleus, an area of growing interest in cellular biology
  • Exercise and metabolic stress response — some studies have investigated how MOTS-c levels change under physiological stress in animal models

As with other emerging research peptides, the literature is still developing. Most published findings to date come from preclinical (cell or animal model) research rather than human clinical trials, and researchers should treat conclusions accordingly.

Handling Considerations for Researchers

MOTS-c is typically supplied as a lyophilized powder, consistent with standard peptide handling requirements:

  • Reconstitute with an appropriate sterile diluent under aseptic conditions
  • Store lyophilized powder frozen; store reconstituted solution refrigerated per supplier-specific stability data
  • Avoid repeated freeze-thaw cycles to preserve compound integrity across a study’s duration

Sourcing Considerations

Because MOTS-c is a newer and less commonly synthesized peptide compared to more established research compounds, verifying supplier purity documentation is especially important. Request a Certificate of Analysis confirming both HPLC purity and MS-verified molecular identity before use.

Summary

MOTS-c represents a growing area of interest within mitochondrial biology and metabolic research. Given the relatively early stage of the literature, researchers should prioritize primary peer-reviewed sources and interpret findings within the context of the animal or cellular models used, rather than extrapolating beyond what current studies support.

Frequently asked questions

Where is MOTS-c encoded?

MOTS-c is encoded in mitochondrial DNA (a small open reading frame within the 12S rRNA gene) rather than in nuclear DNA, which makes it a mitochondrial-derived peptide.

What is the current evidence base for MOTS-c?

Most published findings come from preclinical cell and animal models rather than human clinical trials, and the literature is still developing.

Why is purity verification emphasized for MOTS-c?

It is a newer and less commonly synthesized peptide, so researchers should request a Certificate of Analysis confirming HPLC purity and MS-verified molecular identity before use.

References

  1. Kong BS, Lee C, Cho YM. Mitochondrial-encoded peptide MOTS-c, diabetes, and aging-related diseases. Diabetes Metab J. 2023;47:315-324. PubMed
  2. Zheng Y, Wei Z, Wang T. MOTS-c: a promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023;14:1120533. PubMed

Cited for background on peptide chemistry and analytical methods. All products are sold for laboratory research use only.

Scroll to Top

Discover more from Karma Research Peptides

Subscribe now to keep reading and get access to the full archive.

Continue reading